Patanjali launches 'COVID-19 cure' Coronil but authorities can't vouch for it

Updated : June 23, 2020 02:37 PM IST

Patanjali claims that medicine can cure coronavirus within 14 days.

The Ayush ministry refused to comment on this issue while the Indian Council of Medical Research (ICMR) has said they have no idea.

Yoga guru Swami Ramdev-run Patanjali Ayurvedic Medicines on Tuesday launched an Ayurvedic medicine, Coronil, claiming that it will help to treat the novel coronavirus infection.

The company said that clinical control trials of the medicine were carried out adhering to standardized protocols and within the span of 3 to 15 days, all the COVID-19 positive patients transformed into negative ones without observing any mortality.

The medicine is launched after long research that was jointly conducted by the Patanjali Research Institute, Haridwar and the National Institute of Medical Science, Jaipur.

Patanjali claims that medicine can cure COVID-19 within 14 days.

However, the company has yet not disclosed the details of the clinical studies for the tablet while sources said that no approval has been granted to this drug.

The Ayush ministry refused to comment on this issue while the Indian Council of Medical Research (ICMR) has said they have no idea.

Besides, the government notification bars companies from advertising a cure without government approval.

The medicine was launched with the team of scientists, researchers and doctors involved in the trials at Patanjali Yogpeeth in Haridwar, Uttarakhand.

The tablet will be made available in the Patanjali stores in the next one week, Swami Ramdev said at the launch of the medicine.

“Proud launch of first and foremost evidence-based ayurvedic medicine for corona contagion, CORONIL, is scheduled for tomorrow at 12 noon from Patanjali Yogpeeth Haridwar,” Balkrishna had tweeted on Monday.

Earlier this month, Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali Ayurveda had claimed that the company has found a cure for COVID-19 disease.

In May, the Ayush ministry had allowed clinical trials of 4 ayurvedic 'rasayanas' for the treatment of coronavirus.

Patanjali launches 'COVID-19 cure' Coronil but authorities can't vouch for it

You May Also Like

Wipro's BFSI business to grow with $1.45 billion acquisition of Capco

Wipro to buy UK-based consultancy Capco for $1.45 bn, its biggest acquisition so far

Seeing a commodity boom; gold prices to settle at $1,700-1800/oz in 2021: Citi's Edward Morse

Trending on CNBC-TV18

recommended for you